Shaanxi BLOOM Tech Co., Ltd. yog ib qho ntawm cov tuam ntxhab thiab cov muag khoom ntawm nicotinamide riboside txhaj tshuaj hauv Suav teb. Txais tos rau cov lag luam wholesale bulk zoo nicotinamide riboside txhaj rau muag ntawm no los ntawm peb lub hoobkas. Kev pabcuam zoo thiab tus nqi tsim nyog muaj.
Nicotinamide Riboside Txhaj Tshuajyog ib hom tshuaj uas ncaj qha txhaj tshuaj Nicotinamide Riboside (NR) mus rau hauv lub cev, aiming kom ceev ceev cov concentration ntawm NR nyob rau hauv cov ntshav thiab cov ntaub so ntswg, yog li nce qib ntawm nicotinamide adenine dinucleotide (NAD ⁺) hauv hlwb. Nws yog ib tug derivative ntawm vitamin B3 (niacin) thiab ib tug precursor ntawm NAD ⁺, uas yuav tsum supplemented los ntawm qhov ncauj los yog txhaj tshuaj. Nws daim ntawv txhaj tshuaj yog kom yaj NR nyob rau hauv physiological saline los yog cov kuab tshuaj tshwj xeeb, thiab muab nws intravenously (IV) los yog intramuscularly (IM) kom bypass lub plab hnyuv barrier ntawm lub qhov ncauj nqus thiab ua tau zoo dua bioavailability.
Nyob rau tib lub sijhawm, peb lub tuam txhab tsis yog tsuas yog muab cov hmoov ntshiab, tab sis kuj muaj cov ntsiav tshuaj thiab tshuaj txhaj. Yog tias xav tau, thov koj xav tiv tauj peb txhua lub sijhawm.
Peb cov khoom
 |
 |
 |
 |
Nicotinamide Riboside Chloride COA
Tsim Nicotinamide Riboside Txhaj Tshuaj Raws li Archaea Mammalian Hybrid Enzyme
Nicotinamide Riboside (NR), uas yog lub hauv paus tseem ceeb ntawm NAD ⁺ (nicotinamide adenine dinucleotide), tau dhau los ua lub ntsiab lus kub hauv kev tshawb fawb biomedical vim nws muaj peev xwm tiv thaiv - kev laus, kev txhim kho metabolic, thiab kev tiv thaiv neuroprotection. Txawm li cas los xij, lub qhov ncauj bioavailability ntawm NR yog txwv los ntawm kev ua haujlwm ntawm lub plab zom mov thiab ua ntej dhau cov metabolism, thaum cov tshuaj txhaj tshuaj ib txwm ntsib teeb meem xws li kev ruaj ntseg tsis zoo thiab ib nrab luv luv-lub neej.Nyob rau hauv xyoo tas los no, kev ua tiav hauv cov tshuab hluav taws xob hluavtaws tau muab cov tswv yim tshiab los daws qhov teeb meem no: los ntawm kev tsim cov archaeal mammalian hybrid tsim, ruaj khov thiab kev xa khoom NR. thiab tsim ib tiam tshiab ntawmNicotinamide Riboside Txhaj Tshuajkev daws teeb meem.
Kev Tshawb Fawb Txog Kev Tshawb Fawb: Ua tiav ntawm Archaea thiab Mammalian Enzymes
Extreme ib puag ncig adaptability ntawm archaeal enzymes
Archaea yog ib hom kab mob prokaryotic uas nyob hauv qhov chaw huab cua xws li kub, ntsev, thiab muaj zog acid. Nws cov enzyme system muaj qhov tshwj xeeb stability thiab catalytic efficiency. Piv txwv li:
NR kinase (NRK) ntawm hyperthermophilic archaea (xws li Pyrococcus furiosus) tseem ua haujlwm ntawm 80℃thiab muaj kev sib raug zoo rau cov substrate NR uas ntau dua 10 npaug ntawm cov tsiaj nyeg NRK.
NMN adenosyltransferase (NMNAT) ntawm ntsev archaea, xws li Halobacterium salinarum, tuaj yeem ua rau kev hloov pauv ntawm NMN rau NAD ⁺ nyob rau hauv cov ntsev siab thiab tsis yooj yim degraded los ntawm proteases nyob rau hauv mammalian serum.
Precise tswj ntawm mammalian enzymes
Cov kab mob mammalian enzyme muaj cov ntaub so ntswg nruj thiab kev tswj kev muaj peev xwm metabolic:
Tib neeg NRK1/2: NRK1 tau qhia ntau heev hauv daim siab thiab cov leeg pob txha, lub luag haujlwm rau thawj phosphorylation ntawmNicotinamide Riboside Txhaj Tshuaj; NRK2 feem ntau yog qhia hauv lub hlwb thiab koom nrog neuronal NAD ⁺ synthesis.
SIRT1-3 deacetylase: Nws tswj lub zog metabolism, kho DNA, thiab inflammatory teb los ntawm sensing NAD ⁺, tsim ib tug tsis zoo tswv yim tswj voj.
Tsim Logic ntawm Heterozygous Enzymes
Los ntawm kev sib txuas cov kev ruaj ntseg / catalytic efficiency ntawm archaeal enzymes nrog cov kev cai tshwj xeeb ntawm mammalian enzymes, "dual functional" hybrid enzymes tuaj yeem tsim:
Structureal domain fusion: Piv txwv li, lub catalytic domain ntawm P. furiosus NRK yog fused nrog cov membrane localization teeb liab peptide ntawm tib neeg NRK1 kom ua tau sai phosphorylation ntawm NR nyob ze ntawm lub cell membrane.
Cov kev cai sib txawv: Qhia txog NAD ⁺ binding domain ntawm mammalian SIRT1 dynamically tswj cov kev ua ntawm heterozygous enzymes los ntawm intracellular NAD ⁺ qib, tsis txhob noj ntau dhau ntawm NR.
Txoj Kev: Los ntawm Enzyme Design to Injection Development
Rational Tsim ntawm Heterozygous Enzymes
Hom phiaj xaiv enzyme
Core enzymes: NRK (catalyzing NR → NMN) thiab NMNAT (catalyzing NMN → NAD ⁺), raws li lawv ncaj qha txiav txim siab qhov kev hloov pauv ntawm NR.
Cov enzymes pab, xws li NAMPT (nicotinamide phosphoribosyltransferase), yog siv los rov qab nicotinamide (NAM) thiab ua ke NMN, tsim ib qho kev siv NR.
Domain Spliting thiab Recombination
Noj NRK synthase ua piv txwv:
Archaea seem: Clone NRK noob los ntawm P. furiosus genome, khaws cia nws cov ATP binding domain thiab catalytic triad (xws li K123-D245-E278).
Mammalian ib feem: Extract N-terminal transmembrane domain (TM, 1-50 aa) thiab C-terminal PEST degradation signal (400-450 aa) ntawm tib neeg NRK1 los tswj enzyme membrane localization thiab ib nrab-lub neej.
Flexible linker peptide: Inserting (GGGGS) ∝ linker kom txo tau steric hindrance ntawm structural domains.
Qhia Evolutionary Optimization
Los ntawm kev siv PCR yuam kev thiab fluorescence activated cell sorting (FACS), cov mutants hauv qab no tau soj ntsuam:
Txhim kho siab -qhov kub thiab txias: Qhia T215I kev hloov pauv mus rau hauv lub hnab catalytic ntawm P. furiosus NRK txuas ntxiv ib nrab - lub neej ntawm cov enzyme los ntawm 2 teev mus rau 12 teev ntawm 37℃.
Substrate tshwj xeeb txuas ntxiv: Qhia txog F198L kev hloov pauv ntawm tib neeg NRK2 rau hauv cov enzyme heterozygous, ua rau nws siv tib lub sijhawm siv NR thiab nicotinate ribose (NaR) ua substrates.
Kev nthuav qhia thiab Purification ntawm Heterozygous Enzymes
Expression System Xaiv
Pichia pastoris system: tsim nyog rau kev qhia secretory, tuaj yeem zam kev sib kis ntawm endotoxin, tab sis yuav tsum tau ua kom zoo dua ntawm methanol induction tej yam kev mob los tiv thaiv degradation los ntawm heterozygous enzymes.
Mammalian cell system (HEK293): Nws tuaj yeem ua tiav qhov kev hloov kho glycosylation thiab txhim kho cov ntshav ruaj khov ntawm cov enzymes, tab sis tus nqi kuj tseem siab.
Purification Strategy
Affinity chromatography: Ntxiv Nws ₆ tag rau C-terminus ntawm heterozygous enzyme thiab ntxuav nrog Ni NTA resin.
Ion pauv chromatography: sib cais ntxiv ntawm cov nqi sib txawv siv Mono Q kem.
Loj cais chromatography (SEC): Tshem tawm oligomers kom tau txais monodisperse heterozygous enzymes.
Kev txhim kho ntawm Hybrid Enzyme Npaj
Txhim khu kev ruaj ntseg
Kev hloov kho tshuaj: Polyethylene glycol (PEG) yog siv los hloov cov lysine residues nyob rau saum npoo ntawm heterozygous enzyme, ncua nws ib nrab - lub neej hauv cov ntshav (los ntawm 2 teev mus rau 24 teev).
Nano encapsulation: Loading hybrid enzymes rau hauv liposomes los yog polymer nanoparticles los tiv thaiv lawv ntawm protease degradation.
Txhaj tsim
Txias cov hmoov qhuav qhuav: Sib tov heterozygous enzymes nrog khov -cov tshuaj tiv thaiv kom qhuav xws li sucrose thiab mannitol, khov qhuav ntawm -80℃, thiab yaj hauv PBS nrog pH 7.4 kom pom kev ruaj ntseg.
Kev npaj ua haujlwm ntev microsphere: PLGA (poly (lactic acid glycolic acid) copolymer yog siv los encapsulate lub heterozygous enzyme, ua tiav kev tso tawm rau 14 hnub.
Hauv vitro thiab hauv vivo validation
Kev kuaj ntshav hauv vitro
Enzyme kinetic parameters: Km (0.12 mM) thiab Vmax (150 nmol / min / mg) ntawm heterozygous enzyme rauNicotinamide Riboside Txhaj Tshuajtau txiav txim siab, uas tau zoo dua li cov tsiaj qus-hom P. furiosus NRK (Km=0.5} mM, Vmax=80 nmol/min/mg).
Kev sim ntawm tes: Hauv HepG2 lub siab hlwb, qib NAD ⁺ hauv pawg kho mob heterozygous enzyme yog peb zaug siab dua li hauv NR ib leeg kho mob, thiab tsis ua rau cytotoxicity (LDH tso tawm tus nqi<5%).
Tsiaj Model Validation
Cov qauv nas laus: 18 lub hlis C57BL / 6 nas tau txhaj tshuaj intraperitoneally nrog heterozygous enzyme (5 mg / kg / lub lis piam) rau 8 lub lis piam. Tom qab 8 lub lis piam, lub siab NAD ⁺ qib nce los ntawm 40%, thiab kev ua haujlwm ntawm mitochondrial respiratory chain complex kuv tau rov qab mus rau theem ntawm cov nas me.
Mitochondrial myopathy qauv: Tom qab txhaj tshuaj heterozygous enzymes rau hauv Sco2 knockout nas, cov leeg nqaij muaj zog nce los ntawm 25% thiab kev tawm dag zog tau txuas ntxiv los ntawm 30%.
Cov teeb meem tseem ceeb thiab kev daws teeb meem
Immunogenicity teeb meem
Kev Sib Tw: Heterologous sequences ntawm archaeal enzymes tuaj yeem ua rau lub cev tiv thaiv kab mob (xws li kev tsim tshuaj -cov tshuaj tiv thaiv kab mob, ADA).
Kev hloov kho tib neeg: Siv khoos phis tawj- pab tsim (Rosetta) los hloov cov amino acids saum npoo ntawm archaea enzymes nrog siab -frequency human residues (xws li hloov L102 ntawm P. furiosus NRK nrog V102 ntawm tib neeg NRK1).
Kev tiv thaiv kab mob tiv thaiv kab mob: Ua ntej txhaj tshuaj thawj zaug, qis - koob tshuaj heterozygous enzyme (0.1 mg / kg) tau raug txhawb ua ntej los txhawb kev nthuav dav ntawm kev tswj T hlwb (Treg).
Enzyme Stability thiab Ib nrab Lub Neej
Kev Sib Tw: Muaj ntau yam proteases tam sim no nyob rau hauv mammalian serum, xws li neutrophil elastase, uas yuav degrade heterozygous enzymes.
Kev taw qhia kev hloov pauv: Qhia proline (P) ntawm qhov chaw protease cleavage ntawm ib heterozygous enzyme (xws li K150-R151 ntawm tib neeg NRK1) los thaiv kev sib cais.
Fusion protein lub tswv yim: Fusing lub heterozygous enzyme nrog cov ntshav albumin binding domain (xws li Domain III ntawm HSA), siv lub ntuj stability ntawm albumin mus cuag ib nrab -lub neej.
Kev tsis txaus ntawm cov txheej txheem metabolic
Kev Sib Tw: Kev sib ntxiv ntawm NR tuaj yeem ua rau muaj qhov tsis txaus ntseeg hauv NAD ⁺ / NADH piv, ua rau muaj kev ntxhov siab oxidative.
Kev tawm tswv yim inhibition tsim: Qhia NAD ⁺ binding domain ntawm mammalian SIRT3 rau hauv heterozygous enzyme, thiab cia li downregulate enzyme kev ua si thaum NAD ⁺ qib siab dhau lawm.
Kev tswj hwm ua ke: Siv ua ke nrog cov tshuaj tua kab mob antioxidant (xws li N-acetylcysteine, NAC) los tswj cov cellular redox tshuav nyiaj li cas.
Bottlenecks nyob rau hauv Loj Scale Production
Kev Sib Tw: Cov theem qhia ntawm archaeal enzymes tsawg (feem ntau<10 mg/L), making it difficult to meet clinical needs.
Codon optimization: Hloov cov codons tsawg ntawm cov noob caj noob ces nrog siab - zaus codons ntawm cov poov xab / tsiaj txhu (xws li hloov AGG nrog CGA).
High density fermentation: siv lub perfusion bioreactor (xws li Xcellerex XDR-500) los ua kom cov enzymes heterozygous ntau dua 50 mg / L.
Kev cia siab yav tom ntej
Precision Medical Applications
Genotyping coj txoj kev kho: Los ntawm kev kuaj pom tus neeg mob NRK1/2 gene polymorphism (xws li rs12792273), kho qhov ntau npaum li cas thiab txhaj tshuaj ntau zaus ntawm heterozygous enzymes.
Cov ntaub so ntswg-Kev xa tshwj xeeb: Siv cov tshuaj tiv thaiv kab mob enzyme conjugates (AEC), tsom xa cov enzymes heterozygous mus rau daim siab (ASGPR antibody) lossis lub hlwb (TfR antibody).
Multi enzyme kev sib koom tes system
Tsim kom muaj "NR synthesis conversion rov qab" tag nrho cov saw hybrid enzyme system:
NR synthase: Fusing NR synthase los ntawm archaea Methanococcus jannaschii nrog tib neeg NAMPT kom tau txais kev hloov pauv ncaj qha los ntawm NAM rau NR.
NAD ⁺ sensor: Qhia lub teeb tswj kev hloov pauv (xws li lub teeb pom kev zoo ion channel) kom tswj tau qhov kev ua haujlwm ntawm heterozygous enzymes los ntawm xiav lub teeb irradiation.
Clinical conversion pathway
Kev sim Phaj I: Kev nce ib koob tshuaj (0.1-10 mg / kg) hauv cov neeg ua haujlwm noj qab haus huv, saib xyuas cov tshuaj pharmacokinetics (PK) thiab cov tshuaj pharmacodynamics (PD).
Theem II mus sib hais: Ntsuam xyuas cov txiaj ntsig kev txhim kho ntawm heterozygous enzyme txhaj rau kev ua kom muaj zog thiab cov leeg nqaij muaj zog hauv cov neeg mob mitochondrial.
Theem III mus sib hais: multicenter, randomized, ob - qhov muag tsis pom kev sim los xyuas nws lub sij hawm ntev - kev nyab xeeb thiab kev ua tau zoo.
Cov lus nug nquag
Puas yog 'ib leeg' lossis 'ntau'? -- Yam tsawg kawg peb siv lead ua "clones"
+
-
Nicotinamide ribosyl chloride (NRCl) muaj nyob rau hauv ntau hom siv lead ua thiab muaj ntau yam physicochemical zog. Yam tsawg kawg peb cov ntaub ntawv siv lead ua tau raug tshaj tawm thiab ua rau tam sim no:
Crystal cov ntaub ntawv A thiab B: ob qho tib si yog polymorphs tseeb ntawm cov tshuaj anhydrous.
Crystal form C: Nws yog pseudo polymorphic daim ntawv ntawm methanol solvate.
Kev ruaj ntseg qeb duas: Cov kev sib raug zoo ntawm lub cev tau raug tsim los, ntawm cov siv lead ua B tau raug lees paub tias yog cov qauv siv lead ua ruaj khov tshaj plaws, thiab nws cov qauv siv lead ua tau txiav txim siab los ntawm ib leeg siv lead ua X-ray diffraction tsom xam. Qhov no txhais tau hais tias NR hmoov los ntawm ntau qhov chaw yuav muaj qhov sib txawv hauv kev ruaj ntseg vim lawv cov ntaub ntawv sib txawv.
Nws melting point yog dab tsi? --Cov lus teb tau muab zais rau hauv 'pre melting decomposition'
+
-
Cov ntaub ntawv tsis qhia "lub ntsiab lus melting", tsuas yog "melting range + decomposition". Txoj kev tshawb no siv qhov sib txawv scanning calorimetry (DSC) ua ke nrog nuclear magnetic resonance hydrogen spectroscopy (¹ H NMR) kom pom tias nicotinamide ribosyl chloride decomposes thaum lub sij hawm yaj. Txias tshuab: Qhov "melting point" koj ntsuas yog qhov pib ntawm cov tshuaj tiv thaiv thermal decomposition, es tsis yog cov khoom yooj yim -kua theem hloov. Yog li ntawd, nws cov kev tshwm sim thermal yuav tsum tau piav raws li "melting nrog los ntawm decomposition" es tsis yog ib tug taag melting point.
Vim li cas nws "tsis muaj" ntawm lub txee tab sis "suicidal" hauv plab?
+
-
Alkaline catalyzed hydrolysis tshwm sim nyob rau hauv simulated plab hnyuv kua, ua tus "archenemy" nicotinamide. Lub ntsiab degradation mechanism yog alkaline catalyzed hydrolysis: NRCl sai degrades hauv simulated plab hnyuv kua (pH ze rau nruab nrab alkaline), tawg mus rau hauv nicotinamide thiab ribose. Txawm tias tsis tshua muaj neeg nyiam yog tias cov khoom degradation nicotinamide tuaj yeem cuam tshuam cov txiaj ntsig ntawm NR ntawm kev nce NAD ⁺. Yog li, NR tsis tsuas yog xav tau los tiv thaiv plab acid, tab sis kuj muaj cov kua dej hauv plab - cov txheej txheem yuav tsum tau tiv thaiv nws thiab tiv thaiv cov tiam ntawm cov khoom degradation uas ua rau qhov "qhov tshuaj tiv thaiv".
Vim li cas nws qhov kev ntsuam xyuas kev nyab xeeb qhia tau tias muaj kev cuam tshuam rau cov poj niam cev xeeb tub?
+
-
Exposed Boundary (MoE) 76 vs 100- yuav luag tsis txaus. Lub tswv yim 2019 ntawm European Food Safety Authority (EFSA) hais tias:
Rau cov neeg laus zoo tib yam: Raws li kev tshawb fawb txog tshuaj toxicity hauv cov nas thiab dev, qhov raug ciam teb (MoE) muab tau yog 70, uas suav hais tias muaj kev nyab xeeb txaus.
Rau cov poj niam cev xeeb tub thiab lactating cov poj niam, MoE muab los ntawm kev loj hlob toxicity kev tshawb fawb nyob rau hauv nas yog 76. Vim tsis muaj cov ntaub ntawv uas muaj peev xwm ua pov thawj tias cov nqi qis dua 100 tau txais, 76 yog suav tias yog tsis txaus.
Cov ntsiab lus: Raws li hom khoom noj tshiab, NR muaj kev nyab xeeb rau cov neeg laus zoo tib yam (pom zoo siab txwv ntawm 300 mg / hnub), tab sis rau cov poj niam cev xeeb tub thiab lactating cov poj niam, qhov pom zoo kom noj kom zoo yog txo rau 230 mg / hnub. Nws tsis muaj tshuaj lom, nws tsuas yog tias qhov kev nyab xeeb ntawm cov npoo tsis dav txaus.
Sib nrug los ntawm kev tiv thaiv- kev laus, nws yog dab tsi yog "kev zais zais" hauv kev ua haujlwm biomanufacturing?
+
-
Nws yog "lub hnub qub khoom" ntawm fermentation zoo nyob rau hauv hluavtaws biology, nrog ib tug tawm los ntawm 11.33 g / L. Kev tshawb fawb tshiab (2023) ntawm kev hloov kho ntawm Bacillus licheniformis:
Knocking out degradation genes (deoD/pupG) tiv thaiv NR los ntawm kev puas tsuaj.
Knocking tawm txoj kev byproduct (pncA) txo cov nicotinic acid ntau lawm.
Overexpression ntawm nucleotidase (YfkN) txhawb kev hloov pauv ntawm precursor NMN rau NR.
Thawj zaug, nws tau pom tias MdtL efflux twj tso kua mis (los ntawm Escherichia coli) tuaj yeem txhawb nqa NR secretion.
Thaum kawg, qhov kev ua kom zoo tshaj plaws tau ua tiav cov txiaj ntsig ntawm 11.33 g / L thiab kev hloov pauv ntawm 0.91 mol / mol nicotinamide NR hauv co flasks, uas tseem yog cov khoom lag luam tseem ceeb rau cov chaw tsim khoom microbial cell.
Cim npe nrov: nicotinamide riboside txhaj, lwm tus neeg, manufacturers, hoobkas, lag luam wholesale, yuav, nqe, tej, kev muag khoom